๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck

โœ Scribed by Ralph R. Weichselbaum; Daniel Miller; Susan W. Pitman; John Kirkwood

Publisher
Elsevier Science
Year
1978
Tongue
English
Weight
458 KB
Volume
4
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Methotrexate content in squamous cell ca
Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate
โœ Schifeling, David J. ;George, Todd ;McGuirt, Fred ;Capizzi, Robert L. ;Kamen, Ba ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 232 KB

## Abstract Eleven patients with squamous carcinoma of the head and neck who were scheduled for surgical resection or endoscopic biopsy of tumor received 15 mg/m^2^ of methotrexate (MTX). Samples of tumor, normal mucosa, and plasma were obtained at surgery or endoscopy, 18โ€24 hours after the last M

Thirty-six-hour preoperative high-dose m
Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neck
โœ Hande, K. R. ;Chretien, P. B. ;Elias, E. G. ;Goldberg, N. H. ;Brooks, A. E. ;Cha ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 330 KB

Twenty 36-hour infusions of high-dose methotrexate were given preoperatively to 10 patients with head and neck cancer. Plasma methotrexate levels of greater than 1 X 10(-5) M were maintained for 36 hours and declined with primary and secondary plasma half-lives of 1.7 and 9.2 hours following the end